Navigation Links
Sanofi-aventis Stands Behind the Safety of Lantus(R)
Date:6/26/2009

nded by the ADA. The HbA1c test measures average blood glucose levels over the past two- to three-month period.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

Forward Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include product development, product potential projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions and expectations with respect to future events, operations, products and services, and statements regarding future performance. Forward-looking statements are generally identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans" and similar expressions. Although sanofi-aventis' management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi-aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including po
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
2. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
3. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
4. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
5. New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
6. Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
7. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
8. Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre-Cancerous Barretts Esophagus
9. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
10. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
11. VIVUS Initiates Open Label Safety Study of Avanafil for Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Warner Chilcott plc (Nasdaq: ... Chilcott Corporation (the "Company") has commenced a cash ... the conditions set forth in the Company,s Offer ... 15, 2009 (the "Offer to Purchase"), for any ... notes due 2015 (the "Notes"). ,, The Company ...
(Date:12/15/2009)... Volcano Corporation (Nasdaq: VOLC ), a leading ... including Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), ... - designed to enhance the diagnosis and treatment ... the placement of over 2,500 s5 family consoles ... first launched in April 2006, with more than ...
(Date:12/15/2009)... Fenwal Inc., a global leader focused on improving blood ... commitment to provide blood centers with Alyx® system supplies ... lawsuit filed yesterday against Fenwal by Haemonetics Corporation ( ... is an advanced medical instrument used worldwide to collect ... in about 30 minutes. ,, Fenwal will ...
Breaking Medicine Technology:Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 2Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 3Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 4Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 5Warner Chilcott Commences Tender Offer for its 8.75% Senior Subordinated Notes due 2015 6Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 3Masimo Receives FDA Clearance for New Rainbow 28R 29 Resposable 28TM 29 Sensor System 52225 1Masimo Receives FDA Clearance for New Rainbow 28R 29 Resposable 28TM 29 Sensor System 52225 2Masimo Receives FDA Clearance for New Rainbow 28R 29 Resposable 28TM 29 Sensor System 52225 3Masimo Receives FDA Clearance for New Rainbow 28R 29 Resposable 28TM 29 Sensor System 52225 4Masimo Receives FDA Clearance for New Rainbow 28R 29 Resposable 28TM 29 Sensor System 52225 5House to Home Services is Selected as a Unique Health Provider 52220 1House to Home Services is Selected as a Unique Health Provider 52220 2Varian Inc to Webcast Conference Call on Third Quarter Fiscal Year 2009 Financial Results 13121 1
... YORK--(BUSINESS WIRE)--Jun 5, 2007 - First-in-human results for,IMC-A12, ... IMCL) and targeted to IGF-1R (insulin-like,growth factor type ... the American Society of Clinical Oncology in Chicago.,The ... must human cancers,and transmits signals that lead to ...
... 2007 – This,year’s American Society of Clinical ... of promising new data presented regarding,Merck KGaA’s ... consistent efficacy and,versatility of this agent in ... cancer (mCRC) and squamous cell,carcinoma of the ...
Other Medicine Technology:Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 2Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal,Antibody IMC-A12 Presented at ASCO 3Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 2Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 3Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 4Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 5Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 6Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 7Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of,Erbitux for Colorectal and Head and Neck Cancer Patients 8
(Date:12/15/2009)... Dec. 15 Our Lady of Lourdes Health ... Jersey hospitals, has agreed to pay the United States ... Medicare, the Justice Department announced today. The two hospitals ... Camden, N.J., and Lourdes Medical Center of Burlington County ... defendant in a suit brought by a whistleblower, Tony ...
(Date:12/15/2009)... associated with lower dementia risk, research finds , , TUESDAY, ... leptin, a hormone that regulates appetite, may guard against ... or 15 years this may be one of many ... Alzheimer,s disease," said senior study author Dr. Sudha Seshadri, ... of Medicine. "Or it may be one of many ...
(Date:12/15/2009)... Diabetes Association and the CDC have released some sobering statistics concerning ... States. Treadmill desks offer employers an effective means of combating this ... ... December 14, 2009 -- Rates of diabetes are climbing across America ... rates. Despite this rise the American Diabetes Association has stated that ...
(Date:12/15/2009)... PARK, Calif., Dec. 15 ... position in the pharmaceutical and bio-tech research ... Marketing Research). Over the past 11 years ... the Physicians Consulting Network (PCN®), which now ... professionals covering both primary care and hard-to-reach ...
(Date:12/15/2009)... Patient advocate Betsy McCaughey, Ph.D., will be ... doesn,t matter whether there,s a public option. The current ... - give government authority over how your doctor treats ... agenda by shifting billions of dollars from Medicare to ... local politicians." ,, Betsy McCaughey is the ...
Breaking Medicine News(10 mins):Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2
... Revenue, SEATTLE, July 1 Adaptis, ... solutions for health payers, today announced that,the ... the prestigious and highly,anticipated Healthcare Informatics 15th ... annually in the magazine,s June 2008 issue., ...
... NORWALK, Conn., July 1 The organic food ... nature intended and often,contains more nutrients than its ... With the popularity of organic food on the ... products more accessible than ever., "The difference ...
... would be prepared to pay higher taxes to fund increased education facilities ... recruitment of nurses from overseas. , ... Carlsbad, Calif. (PRWEB) July 1, ... group healthcare survey are concerned about the on-going effects of a nursing ...
... EnduranceProducts.com, and new products. EP® L-Arginine 350mg Sustained ... arteries and to the muscle of the heart ... in "The Blood Pressure Cure: 8 Weeks to ... Robert E. Kowalski, best-selling author of "The 8-Week ...
... Social Security Disability Insurance applications can be overwhelming; Allsup provides tips ... ... (Vocus) July 1, 2008 -- Every day, people across the United ... condition. According to Allsup, the challenges when faced with these circumstances ...
... more adults age into the high-risk period for cognitive ... where they may have problems in everyday life that ... validated questionnaire called Everyday Cognition (ECog), when filled out ... sensitively evaluate the performance of everyday activities that reflect ...
Other Medicine News:Health News:Adaptis Named 'Top 100' Company for Fifth Consecutive Year 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food 2Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food 3Health News:Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food 4Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 2Health News:Education More Important Than Immigration to Solve Nursing Shortage, Research Shows 3Health News:Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch, New Endurance Products SR L-Arginine and Grape Seed Extract 2Health News:Release of Kowalski Book on Attaining Healthy Blood Pressure Coincides with Website Launch, New Endurance Products SR L-Arginine and Grape Seed Extract 3Health News:Two Categories of Information Are Key in Seeking SSDI Benefits 2Health News:Two Categories of Information Are Key in Seeking SSDI Benefits 3Health News:Two Categories of Information Are Key in Seeking SSDI Benefits 4Health News:New 'everyday cognition' scale tracks how older adults function in daily life 2Health News:New 'everyday cognition' scale tracks how older adults function in daily life 3
... For the qualitative ... falciparum (P.f) antigen and an ... all four species of malaria:plasmodium ... Plasmodium ovale (P.o) and Plasmodium ...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... navigator is a new tool that ... position of any catheter or lead ... cardiac anatomy in the EP intervention ... carry out complex EP procedures with ...
PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD....
Medicine Products: